Electromed (NYSE:ELMD) Posts Earnings Results, Beats Estimates By $0.13 EPS

Electromed (NYSE:ELMD) posted its quarterly earnings data on Tuesday. The company reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.13, Zacks reports. Electromed had a return on equity of 15.32% and a net margin of 11.34%. The business had revenue of $14.67 million for the quarter.

Electromed Trading Up 1.5 %

ELMD traded up $0.43 on Friday, hitting $29.32. 64,655 shares of the stock traded hands, compared to its average volume of 41,593. Electromed has a 52 week low of $9.81 and a 52 week high of $30.00. The firm has a market capitalization of $248.05 million, a PE ratio of 40.11 and a beta of 0.27. The business has a fifty day moving average price of $21.67 and a two-hundred day moving average price of $17.65.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.